UY23606A1 - Procedimiento para la preparacion de derivados del acido hidroxamico.- - Google Patents
Procedimiento para la preparacion de derivados del acido hidroxamico.-Info
- Publication number
- UY23606A1 UY23606A1 UY23606A UY23606A UY23606A1 UY 23606 A1 UY23606 A1 UY 23606A1 UY 23606 A UY23606 A UY 23606A UY 23606 A UY23606 A UY 23606A UY 23606 A1 UY23606 A1 UY 23606A1
- Authority
- UY
- Uruguay
- Prior art keywords
- atom
- preparation
- bonding
- procedure
- het
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- JLLYLQLDYORLBB-UHFFFAOYSA-N 5-bromo-n-methylthiophene-2-sulfonamide Chemical compound CNS(=O)(=O)C1=CC=C(Br)S1 JLLYLQLDYORLBB-UHFFFAOYSA-N 0.000 abstract 1
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 239000004395 L-leucine Substances 0.000 abstract 1
- -1 N-hydroxyamino Chemical group 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 229960003136 leucine Drugs 0.000 abstract 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
- C07C239/08—Hydroxylamino compounds or their ethers or esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
- C07C239/08—Hydroxylamino compounds or their ethers or esters
- C07C239/22—Hydroxylamino compounds or their ethers or esters having oxygen atoms of hydroxylamino groups esterified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929213473A GB9213473D0 (en) | 1992-06-25 | 1992-06-25 | Hydroxamic acid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY23606A1 true UY23606A1 (es) | 1993-12-15 |
Family
ID=10717706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY23606A UY23606A1 (es) | 1992-06-25 | 1993-06-24 | Procedimiento para la preparacion de derivados del acido hidroxamico.- |
Country Status (12)
| Country | Link |
|---|---|
| KR (1) | KR100311556B1 (enExample) |
| BR (1) | BR9302642A (enExample) |
| GB (2) | GB9213473D0 (enExample) |
| HR (1) | HRP930980A2 (enExample) |
| MX (1) | MX9303672A (enExample) |
| MY (1) | MY134743A (enExample) |
| PL (1) | PL299465A1 (enExample) |
| SI (1) | SI9300313A (enExample) |
| TW (1) | TW279157B (enExample) |
| UY (1) | UY23606A1 (enExample) |
| YU (1) | YU40293A (enExample) |
| ZA (1) | ZA934398B (enExample) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8601368D0 (en) * | 1986-01-21 | 1986-02-26 | Ici America Inc | Hydroxamic acids |
| US5189178A (en) * | 1990-11-21 | 1993-02-23 | Galardy Richard E | Matrix metalloprotease inhibitors |
-
1992
- 1992-06-25 GB GB929213473A patent/GB9213473D0/en active Pending
-
1993
- 1993-04-05 GB GB939307081A patent/GB9307081D0/en active Pending
- 1993-06-02 TW TW082104397A patent/TW279157B/zh active
- 1993-06-09 YU YU40293A patent/YU40293A/sh unknown
- 1993-06-10 SI SI9300313A patent/SI9300313A/sl unknown
- 1993-06-16 HR HR9213473.3A patent/HRP930980A2/xx not_active Application Discontinuation
- 1993-06-18 ZA ZA934398A patent/ZA934398B/xx unknown
- 1993-06-18 MX MX9303672A patent/MX9303672A/es not_active IP Right Cessation
- 1993-06-23 MY MYPI93001217A patent/MY134743A/en unknown
- 1993-06-24 KR KR1019930011598A patent/KR100311556B1/ko not_active Expired - Fee Related
- 1993-06-24 UY UY23606A patent/UY23606A1/es unknown
- 1993-06-24 BR BR9302642A patent/BR9302642A/pt not_active Application Discontinuation
- 1993-06-24 PL PL93299465A patent/PL299465A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX9303672A (es) | 1994-01-31 |
| BR9302642A (pt) | 1994-01-11 |
| ZA934398B (en) | 1993-12-27 |
| YU40293A (sh) | 1997-07-31 |
| PL299465A1 (en) | 1994-03-07 |
| GB9307081D0 (en) | 1993-05-26 |
| KR940005556A (ko) | 1994-03-21 |
| TW279157B (enExample) | 1996-06-21 |
| SI9300313A (sl) | 1993-12-31 |
| MY134743A (en) | 2007-12-31 |
| KR100311556B1 (ko) | 2002-02-19 |
| HRP930980A2 (en) | 1997-02-28 |
| GB9213473D0 (en) | 1992-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2662162B1 (fr) | Nouveaux derives de l'amino piperidine, de l'amino pyrrolidine et de l'amino perhydroazepine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. | |
| ATE228115T1 (de) | Bizyklische fibrinogenantagonisten | |
| ES2158778B1 (es) | Compuestos de sales de paroxetina, su preparacion y uso, y composiciones farmaceuticas que los contienen. | |
| MX9203744A (es) | Analogos de camptotecina solubles en agua utiles para inhibir el crecimiento de celulas de tumor de animal. | |
| KR890011592A (ko) | 기관내 허혈병의 치료용 조성물 | |
| EA200500088A1 (ru) | Трициклические модуляторы ядерного рецептора стероидного гормона | |
| AR042368A1 (es) | Un compuesto derivado de purina, su uso, un procedimiento para prepararlo y una composicion farmaceutica que lo comprende | |
| ES2202322T3 (es) | Uso de tiazolidinadionas para el tratamiento de la ateroesclerosis y trastornos de la alimentacion. | |
| NO160076C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazol- og benzotianolaminderivater. | |
| JP2009541484A (ja) | ５ｈｔ６モジュレーターおよびコリンエステラーゼインヒビターを含む組み合わせ | |
| ES2139673T3 (es) | Utilizacion de norastemizol para el tratamiento de rinitis alergica. | |
| DK491489A (da) | Imidazolinderivater samt fremgangsmaade til fremstilling deraf | |
| NO943895L (no) | Galantaminderivater, en fremgangsmåte for fremstilling samt deres anvendelse som medikamenter | |
| ES2051834T3 (es) | El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad. | |
| DE69501359D1 (de) | Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina | |
| DE68917937D1 (de) | Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung. | |
| MX9202146A (es) | Derivados de aminoacido, procedimiento para su preparacion y medicamento que los contienen. | |
| AR040240A1 (es) | Derivados de acido 3-mercaptopentanoico 2.5-disustituido | |
| AR032598A1 (es) | Oxazinquinolonas, una composicion farmaceutica y el uso de las mismas para preparar un medicamento utiles en el tratamiento de infecciones virales | |
| KR100759771B1 (ko) | 성상세포 기능 개선제를 유효 성분으로 함유하는 파킨슨병치료제 | |
| DE69217613D1 (de) | Stickstoff enthaltende bizyklische Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen | |
| NO913023D0 (no) | Nye bicykliske aminosubstituerte forbindelsr. | |
| KR950702544A (ko) | 비페닐메탄 유도체 및 이를 함유하는 약제 | |
| DE68903019D1 (de) | 4,5,6,7-tetrahydroisothiazolo (4,5-c)pyridin-derivate und isomere. | |
| NO950177D0 (no) | Farmakologisk aktive erivater |